0
     

Report Added
Report already added
North America Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Country: Trend Forecast and Growth Opportunity

North America Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Country: Trend Forecast and Growth Opportunity

North America bioanalytical testing services market is projected to grow by 8.3% annually in the forecast period and reach $ 3,232.3 million by 2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach.

Highlighted with 29 tables and 75 figures, this 130-page report “North America Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America bioanalytical testing services market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America bioanalytical testing services market in every aspect of the classification from perspectives of Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Country.

Based on Molecule Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Small Molecules
Large Molecules
LC-MS Studies
Immunoassays
Other Large Molecule Tests

Based Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Bioavailability and Bioequivalence Studies
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Absorption, Distribution, Metabolism, Excretion (ADME)
Other Applications

By Test Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Cell-based Assays
Bacterial Cell-based Assays
Viral Cell-based Assays
Virology Testing
In Vitro Virology Testing
In Vivo Virology Testing
Species-Specific Viral PCR Assays
Serology, Immunogenicity, and Neutralizing Antibodies (SINA)
Bacterial Serology, Immunogenicity, and Neutralizing Antibodies
Viral Serology, Immunogenicity, and Neutralizing Antibodies
Method Development Optimization and Validation (MDOV)
Biomarker Testing
Pharmacokinetic Testing
Other Test Types

By Workflow Process, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Sample Preparation
Protein Precipitation
Liquid-liquid Extraction (LLE)
Sample Analysis
Hyphenated Technique
Chromatographic Technique
Electrophoresis
Ligand Binding Assay
Mass Spectrometry
Nuclear Magnetic Resonance
Other Workflow Processes

By Therapeutic Area, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Oncology
Neurology
Infectious Diseases
Gastroenterology
Cardiology
Other Therapeutic Areas

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
Pharma and Biopharma Companies
Contract Development and Manufacturing Organizations (CDMOs)
Contract Research Organizations (CROs)

Geographically, the following national/local markets are fully investigated:
•U.S.
•Canada
•Mexico

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Application, Workflow Process, and Therapeutic Area over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:
Charles River Laboratories International Inc.
Covance Inc.
Eurofins Scientific
ICON PLC
Intertek Group PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America Holdings
Medpace Holdings, Inc.
Pace Analytical Services LLC.
Parexel International Corporation
PPD Inc.
SGS SA
Syneos Health, LLC
Toxikon Corporation
WuXi Apptech Co., Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction8
1.1 Industry Definition and Research Scope8
1.1.1 Industry Definition8
1.1.2 Research Scope9
1.2 Research Methodology12
1.2.1 Overview of Market Research Methodology12
1.2.2 Market Assumption13
1.2.3 Secondary Data13
1.2.4 Primary Data13
1.2.5 Data Filtration and Model Design14
1.2.6 Market Size/Share Estimation15
1.2.7 Research Limitations16
1.3 Executive Summary17
2 Market Overview and Dynamics20
2.1 Market Size and Forecast20
2.1.1 Impact of COVID-19 on World Economy21
2.1.2 Impact of COVID-19 on the Market23
2.2 Major Growth Drivers28
2.3 Market Restraints and Challenges31
2.4 Emerging Opportunities and Market Trends34
2.5 Porter’s Fiver Forces Analysis38
3 Segmentation of North America Market by Molecule Type42
3.1 Market Overview by Molecule Type42
3.2 Small Molecules44
3.3 Large Molecules45
3.3.1 LC-MS Studies46
3.3.2 Immunoassays47
3.3.3 Other Large Molecule Tests48
4 Segmentation of North America Market by Application49
4.1 Market Overview by Application49
4.2 Bioavailability and Bioequivalence Studies51
4.3 Pharmacokinetics (PK)52
4.4 Pharmacodynamics (PD)53
4.5 Absorption, Distribution, Metabolism, Excretion (ADME)54
4.6 Other Applications55
5 Segmentation of North America Market by Test Type56
5.1 Market Overview by Test Type56
5.2 Cell-based Assays58
5.2.1 Bacterial Cell-based Assays59
5.2.2 Viral Cell-based Assays60
5.3 Virology Testing61
5.3.1 In Vitro Virology Testing62
5.3.2 In Vivo Virology Testing63
5.3.3 Species-Specific Viral PCR Assays64
5.4 Serology, Immunogenicity, and Neutralizing Antibodies (SINA)65
5.4.1 Bacterial Serology, Immunogenicity, and Neutralizing Antibodies66
5.4.2 Viral Serology, Immunogenicity, and Neutralizing Antibodies67
5.5 Method Development Optimization and Validation (MDOV)68
5.6 Biomarker Testing69
5.7 Pharmacokinetic Testing70
5.8 Other Test Types71
6 Segmentation of North America Market by Workflow Process72
6.1 Market Overview by Workflow Process72
6.2 Sample Preparation74
6.2.1 Protein Precipitation75
6.2.2 Liquid-liquid Extraction (LLE)76
6.2.3 Solid Phase Extraction (SPE)77
6.3 Sample Analysis78
6.3.1 Hyphenated Technique80
6.3.2 Chromatographic Technique81
6.3.3 Electrophoresis82
6.3.4 Ligand Binding Assay83
6.3.5 Mass Spectrometry84
6.3.6 Nuclear Magnetic Resonance85
6.4 Other Workflow Processes86
7 Segmentation of North America Market by Therapeutic Area87
7.1 Market Overview by Therapeutic Area87
7.2 Oncology89
7.3 Neurology90
7.4 Infectious Diseases91
7.5 Gastroenterology92
7.6 Cardiology93
7.7 Other Therapeutic Areas94
8 Segmentation of North America Market by End User95
8.1 Market Overview by End User95
8.2 Pharma and Biopharma Companies97
8.3 Contract Development and Manufacturing Organizations (CDMOs)98
8.4 Contract Research Organizations (CROs)99
9 North America Market 2021-2031 by Country100
9.1 Overview of North America Market100
9.2 U.S.103
9.3 Canada106
9.4 Mexico108
10 Competitive Landscape110
10.1 Overview of Key Vendors110
10.2 New Product Launch, Partnership, Investment, and M&A113
10.3 Company Profiles114
Charles River Laboratories International Inc.114
Covance Inc.116
Eurofins Scientific117
ICON PLC118
Intertek Group PLC119
IQVIA Holdings, Inc.120
Laboratory Corporation of America Holdings121
Medpace Holdings, Inc.122
Pace Analytical Services LLC.123
Parexel International Corporation124
PPD Inc.125
SGS SA126
Syneos Health, LLC127
Toxikon Corporation128
WuXi Apptech Co., Ltd.129
RELATED REPORTS130

List of Tables:

Table 1. Snapshot of North America Bioanalytical Testing Services Market in Balanced Perspective, 2021-203118
Table 2. World Economic Outlook, 2021-203122
Table 3. World Health Spending by Region, $ bn, 2013-202027
Table 4. Main Product Trends and Market Opportunities in North America Bioanalytical Testing Services Market34
Table 5. North America Bioanalytical Testing Services Market by Molecule Type, 2021-2031, $ mn42
Table 6. North America Bioanalytical Testing Services Market: Large Molecules Testing by Technology, 2021-2031, $ mn45
Table 7. North America Bioanalytical Testing Services Market by Application, 2021-2031, $ mn49
Table 8. North America Bioanalytical Testing Services Market by Test Type, 2021-2031, $ mn56
Table 9. North America Bioanalytical Testing Services Market: Cell-based Assays by Type, 2021-2031, $ mn58
Table 10. North America Bioanalytical Testing Services Market: Virology Testing by Type, 2021-2031, $ mn61
Table 11. North America Bioanalytical Testing Services Market: Serology, Immunogenicity, and Neutralizing Antibodies (SINA) by Type, 2021-2031, $ mn65
Table 12. North America Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn72
Table 13. North America Bioanalytical Testing Services Market: Sample Preparation by Method, 2021-2031, $ mn74
Table 14. North America Bioanalytical Testing Services Market: Sample Analysis by Technology, 2021-2031, $ mn79
Table 15. North America Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn87
Table 16. North America Bioanalytical Testing Services Market by End User, 2021-2031, $ mn95
Table 17. North America Bioanalytical Testing Services Market by Country, 2021-2031, $ mn101
Table 18. U.S. Bioanalytical Testing Services Market by Application, 2021-2031, $ mn105
Table 19. U.S. Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn105
Table 20. U.S. Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn105
Table 21. Canada Bioanalytical Testing Services Market by Application, 2021-2031, $ mn107
Table 22. Canada Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn107
Table 23. Canada Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn107
Table 24. Mexico Bioanalytical Testing Services Market by Application, 2021-2031, $ mn109
Table 25. Mexico Bioanalytical Testing Services Market by Workflow Process, 2021-2031, $ mn109
Table 26. Mexico Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, $ mn109
Table 27. Charles River Laboratories International Inc.: Company Snapshot114
Table 28. Charles River Laboratories International Inc.: Business Segmentation115
Table 29. Charles River Laboratories International Inc.: Product Portfolio115

Report Title: North America Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Country: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Dental Imaging Systems: Global Markets

Dental Imaging Systems: Global Markets

Telecom operators’ strategies in the health market

Telecom operators’ strategies in the health market

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline